Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results

v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008

v15i1: pp. 93-104 David Boyd; Thomas R. Ireland Antitrust 2008
U.S. Life Expectancy Tables Extended from Age 100 to Age 120
2 × $25.00
Scope of discovery of an expert's work product
1 × $25.00 Subtotal: $75.00